EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases

Lisa Kobrynski

Biologics: Targets and Therapy · 2012-08 · 277

DOI: 10.2147/btt.s25188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biologics: Targets and Therapy, 2012-08. Verfasst von Lisa Kobrynski. Beteiligte Einrichtung: Department of Pediatrics, Emory University, Atlanta, GA, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

immunoglobulin Gprimary immunodeficiency diseasessubcutaneous immunoglobulin

Autor:innen und Institutionen

  • Department of Pediatrics, Emory University, Atlanta, GA, USA.

Zitieren

APA

Kobrynski, L. (2012). Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics: Targets and Therapy, 277. https://doi.org/10.2147/btt.s25188

Vancouver

Kobrynski L. Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics: Targets and Therapy. 2012:277. doi:10.2147/btt.s25188

BibTeX
@article{Kobrynski2012,
  author = {Kobrynski, Lisa},
  title = {Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases},
  journal = {Biologics: Targets and Therapy},
  year = {2012},
  pages = {277},
  doi = {10.2147/btt.s25188}
}
Kostenlos starten →